Fentanyl and hydromorphone accounted for 47% of waste events, the medication software company said in a diversion trends report. Waste events risk drug diversion, the July 11 report said, and the 16 million wasted units led to $38.6 million in lost costs.
Bluesight analyzed more than 127 million controlled substance transactions at 794 hospitals to assess diversion monitoring and investigation timelines. The company found improved diversion monitoring efforts, fewer discrepant transactions and more efficient investigations.
Variances, or discrepancies between the amount of a drug ordered and the amount administered to a patient, mostly happened in nursing departments (77.7%), anesthesiology (11.8%) and pharmacies (5%).
Read more here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
